ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...
Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...
Regenxbio has a competitive advantage in the market with its proprietary NAV technology platform, based on AAV vectors, that is highly effective, efficient, and scalable. The recent Phase II trial on ...
OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...
Demand for lentiviral vectors will continue to outstrip supply until the industry has access to more efficient, purpose-built manufacturing and bioprocessing technologies. The warning comes from ...
WEST PALM BEACH, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTCID: FOXO) (“FOXO” or the “Company”), announces the closing of the acquisition of Vector Biosource Inc. (“Vector”).
The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved ...
COLLEGE PARK, Md., September 17, 2025--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the leader in the quantum computing and networking industries, today announced it has entered into a definitive agreement to ...
TAMPA, FL and BLOOMINGTON, IN - (Sept. 8, 2021) - Vector Solutions, the leading provider of industry-focused software solutions for training, workforce management and risk communications, has acquired ...
AC vector technology continues to increase in servo applications, such as in an automotive timing-chain manufacturing plant recently serviced by distributor Eastern Bearings Inc., Waltham, Mass. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results